Cite
HARVARD Citation
Sato, A. et al. (2017). Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3′-ethynylcytidine treatment of human cancer cells. Anti-cancer drugs. 28 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sato, A. et al. (2017). Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3′-ethynylcytidine treatment of human cancer cells. Anti-cancer drugs. 28 (7), p. . [Online].